Galmed Pharmaceuticals Files 6-K Report
Ticker: GLMD · Form: 6-K · Filed: 2026-04-09T08:40:13-04:00
Sentiment: neutral
Topics: foreign-issuer, disclosure, routine-filing
TL;DR
Galmed Pharma filed a 6-K on 4/9/26, standard foreign issuer report.
AI Summary
Galmed Pharmaceuticals Ltd. filed a Form 6-K on April 9, 2026, reporting information as a foreign issuer. The filing includes standard documents like the 6-K form itself and an exhibit (EX-99.1). The company's mailing and business addresses are listed as C/O MEITAR LAW OFFICES in Ramat Gan, Israel.
Why It Matters
This filing provides routine updates for Galmed Pharmaceuticals Ltd. as a foreign issuer, which is important for investors tracking the company's compliance and disclosures.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign issuer and does not appear to contain significant new financial or operational information.
Key Players & Entities
- Galmed Pharmaceuticals Ltd. (company) — Filer
- MEITAR LAW OFFICES (company) — Mailing and Business Address
- 0001595353 (company) — Galmed Pharmaceuticals Ltd. CIK
- 2026-04-09 (date) — Filing Date and Period of Report
FAQ
What type of SEC filing is this?
This is a Form 6-K, which is a report of a foreign issuer.
When was this filing made?
The filing date was April 9, 2026.
Who is the filer of this document?
The filer is Galmed Pharmaceuticals Ltd.
What are the listed addresses for Galmed Pharmaceuticals Ltd. in this filing?
The mailing and business addresses are both listed as C/O MEITAR LAW OFFICES, 16 ABBA HILLEL SILVER RD., RAMAT GAN L3 5250608.
What are the document types included in this filing?
The filing includes the 6-K form itself and an exhibit labeled EX-99.1.
From the Filing
EDGAR Filing Documents for 0001493152-26-015824 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: SEC Accession No. 0001493152-26-015824 Filing Date 2026-04-09 Accepted 2026-04-09 08:40:13 Documents 2 Period of Report 2026-04-09 Document Format Files Seq Description Document Type Size 1 6-K form6-k.htm 6-K 18166 2 EX-99.1 ex99-1.htm EX-99.1 22166 Complete submission text file 0001493152-26-015824.txt 41437 Mailing Address C/O MEITAR LAW OFFICES 16 ABBA HILLEL SILVER RD. RAMAT GAN L3 5250608 Business Address C/O MEITAR LAW OFFICES 16 ABBA HILLEL SILVER RD. RAMAT GAN L3 5250608 97236938448 Galmed Pharmaceuticals Ltd. (Filer) CIK : 0001595353 (see all company filings) EIN. : 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231 Type: 6-K | Act: 34 | File No.: 001-36345 | Film No.: 26849931 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)